Finafta Spray
NDC Package 58593-782-02
Package Information
Finafta (benzocaine) sprays is uSESFor the temporary relief of occasional minor irritation, pain, sore mouth, pain associated with canker sores or pain due to minor irritation of the mouth and gums cause by dentures or othodontic applicances. This formulation utilizes a spray delivery system. Marketed by Efficient Laboratories Inc., this product is identified by NDC 58593-782 and is authorized under FDA application M022.
Identification & Billing
- RxCUI: 1110816 - benzocaine 7.5 % Mucosal Spray
- RxCUI: 1110816 - benzocaine 75 MG/ML Mucosal Spray
- RxCUI: 1110820 - Finafta Multi Oral 7.5 % Mucosal Spray
- RxCUI: 1110820 - benzocaine 75 MG/ML Mucosal Spray [Finafta Multi Oral]
- RxCUI: 1110820 - Finafta Multi Oral 75 MG/ML Mucosal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58593 - Efficient Laboratories Inc.
- 58593-782 - Finafta
- 58593-782-02 - 1 BOTTLE, SPRAY in 1 CARTON / 59 mL in 1 BOTTLE, SPRAY
- 58593-782 - Finafta
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58593-782-02 identifies a specific commercial package of 1 bottle, spray in 1 carton / 59 ml in 1 bottle, spray of Finafta Multioral, a human over the counter drug labeled by Efficient Laboratories Inc.. This spray is formulated for oral use and contains benzocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Efficient Laboratories Inc. on September 01, 2004. The current certification is valid through December 31, 2026.
How is this Efficient Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58593078202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.